Loading...
Select Medical Holdings Corporation
SEM•NYSE
Healthcare
Medical - Care Facilities
$14.26
$0.12(0.85%)
Select Medical Holdings Corporation (SEM) Financial Performance & Income Statement Overview
Review Select Medical Holdings Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-22.16%
↓ 22.16%
Operating Income Growth
-51.64%
↓ 51.64%
Net Income Growth
-12.10%
↓ 12.10%
Operating Cash Flow Growth
-11.03%
↓ 11.03%
Operating Margin
3.94%
↑ 3.94%
Gross Margin
8.75%
↑ 8.75%
Net Profit Margin
3.66%
↑ 3.66%
ROE
10.33%
↑ 10.33%
ROIC
3.94%
↑ 3.94%
Select Medical Holdings Corporation (SEM) Income Statement & Financial Overview
Review Select Medical Holdings Corporation's (SEM) income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | -$122.59M | $1.76B | $1.76B | $1.79B |
Cost of Revenue | $36.91M | $1.57B | $1.55B | $1.55B |
Gross Profit | -$159.50M | $187.18M | $207.68M | $240.13M |
Gross Profit Ratio | $1.30 | $0.11 | $0.12 | $0.13 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $80.20M | $47.35M | $49.70M | $48.45M |
Operating Expenses | $65.09M | $47.35M | $49.70M | $48.45M |
Total Costs & Expenses | $102.00M | $1.62B | $1.60B | $1.60B |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $0.00 | $55.44M | $37.11M | $50.76M |
Depreciation & Amortization | $36.28M | $50.14M | $53.94M | $54.07M |
EBITDA | -$182.65M | $221.05M | $211.92M | $258.46M |
EBITDA Ratio | $1.49 | $0.13 | $0.12 | $0.14 |
Operating Income | -$224.59M | $141.13M | $157.98M | $191.68M |
Operating Income Ratio | $1.83 | $0.08 | $0.09 | $0.11 |
Other Income/Expenses (Net) | $10.90M | -$33.31M | -$30.79M | -$40.34M |
Income Before Tax | -$213.69M | $107.82M | $127.008M | $153.63M |
Income Before Tax Ratio | $1.74 | $0.06 | $0.07 | $0.09 |
Income Tax Expense | -$50.73M | $26.81M | $32.24M | $36.46M |
Net Income | -$16.05M | $55.63M | $77.56M | $96.90M |
Net Income Ratio | $0.13 | $0.03 | $0.04 | $0.05 |
EPS | -$0.12 | $0.43 | $0.60 | $0.75 |
Diluted EPS | -$0.13 | $0.43 | $0.60 | $0.75 |
Weighted Avg Shares Outstanding | $125.92M | $124.71M | $123.95M | $123.86M |
Weighted Avg Shares Outstanding (Diluted) | $129.18M | $124.71M | $123.95M | $123.86M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan